UNIVERSITY COLLEGE LONDON
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
- Conditions
- Lung Cancer
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 130
- Registration Number
- NCT00309972
- Locations
- 🇬🇧
Clatterbridge Centre for Oncology, Merseyside, England, United Kingdom
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- University College, London
- Target Recruit Count
- 614
- Registration Number
- NCT00310167
- Locations
- 🇬🇧
Cancer Research UK and University College London Cancer Trials Centre, London, England, United Kingdom
Prostate Adenocarcinoma TransCutaneous Hormones
- Conditions
- Hot FlashesAnemiaOsteoporosisProstate CancerCardiovascular Complications
- Interventions
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- University College, London
- Target Recruit Count
- 2200
- Registration Number
- NCT00303784
- Locations
- 🇬🇧
Queen's Hospital, Burton-upon-Trent, England, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, England, United Kingdom
🇬🇧Walsgrave Hospital, Coventry, England, United Kingdom
CMV Glycoprotein B Vaccine in Allograft Recipients
- Conditions
- Cytomegalovirus Infections
- Interventions
- Biological: CMV gB vaccineDrug: Placebo
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2010-04-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 140
- Registration Number
- NCT00299260
- Locations
- 🇬🇧
University College Medical School, London, United Kingdom
Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Drug: Matched placebo
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 670
- Registration Number
- NCT00275132
- Locations
- 🇬🇧
London Lung Cancer Group, London, England, United Kingdom
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
- Conditions
- Extrahepatic Bile Duct CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- University College, London
- Target Recruit Count
- 324
- Registration Number
- NCT00262769
- Locations
- 🇬🇧
Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, England, United Kingdom
🇬🇧Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust, Birmingham, England, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, England, United Kingdom
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabOther: No treatment
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University College, London
- Target Recruit Count
- 462
- Registration Number
- NCT00112931
- Locations
- 🇬🇧
Queen Elizabeth Hospital, King's Lynn, England, United Kingdom
🇦🇺Royal Adelaide Hospital, Adelaide, Australia
🇦🇺Ashford Cancer Centre, Black Forest, Australia
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Drug: Carboplatin, etoposide & thalidomideDrug: Carboplatin, etoposide & placebo
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- University College, London
- Target Recruit Count
- 724
- Registration Number
- NCT00061919
- Locations
- 🇬🇧
University College of London Hospitals, London, England, United Kingdom
CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
- Conditions
- Ovarian Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 202638
- Registration Number
- NCT00058032